Swiss Pharma loses challenge to two Biogen (BIIB) patents on Tsyabri - Bloomberg

October 17, 2016 11:11 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Swiss Pharma loses challenge to two Biogen (NASDAQ: BIIB) patents on Tsyabri, according to Bloomberg. Swiss Pharma has also challenged one other Biogen patent.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Litigation, Trader Talk

Add Your Comment